Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Short-term Investments (2016 - 2017)

Historic Short-term Investments for Dexcom (DXCM) over the last 9 years, with Q4 2017 value amounting to $107.1 million.

  • Dexcom's Short-term Investments rose 26678.08% to $107.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $107.1 million, marking a year-over-year increase of 26678.08%. This contributed to the annual value of $107.1 million for FY2017, which is 26678.08% up from last year.
  • As of Q4 2017, Dexcom's Short-term Investments stood at $107.1 million, which was up 26678.08% from $123.7 million recorded in Q3 2017.
  • In the past 5 years, Dexcom's Short-term Investments registered a high of $123.7 million during Q3 2017, and its lowest value of $11.4 million during Q4 2013.
  • Over the past 5 years, Dexcom's median Short-term Investments value was $28.0 million (recorded in 2015), while the average stood at $35.4 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first tumbled by 7192.12% in 2013, then surged by 31790.54% in 2017.
  • Quarter analysis of 5 years shows Dexcom's Short-term Investments stood at $11.4 million in 2013, then increased by 3.51% to $11.8 million in 2014, then skyrocketed by 146.61% to $29.1 million in 2015, then rose by 0.34% to $29.2 million in 2016, then soared by 266.78% to $107.1 million in 2017.
  • Its Short-term Investments was $107.1 million in Q4 2017, compared to $123.7 million in Q3 2017 and $100.7 million in Q2 2017.